期刊文献+

感染性休克后期患者血管加压素水平对渗透压反应异常的规律探讨 被引量:6

Investigation of vasopressin response to increasing osmotic pressure in the late-phase of septic shockpatients
原文传递
导出
摘要 目的探讨感染性休克后期患者血管加压素(VP)对渗透压升高的反应规律。方法以2012年1月至2013年9月河北医科大学第一医院重症监护病房(ICU)37例感染性休克患者为研究对象,测定其输注3%高渗氯化钠溶液前后血清vP及血钠水平。以输液前后VP和血钠差值的比值(△VP,△Na)≤0.5pg/mmol为无反应组,〉0.5pg/mmol为有反应组,比较两组患者年龄、急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分、血压、血浆白蛋白水平,及血管活性药物使用情况。结果无反应组20例(占54.05%),有反应组17例(占45.95%)无反应组基础VP水平显著低于有反应组(ng/L:10.41±1.70比18.25±5.90,t=5.29,P〈0.01),输注3%高渗氯化钠溶液后无反应组VP水平仍显著低于有反应组(ng/L:11.36±1.90比24.33±5.46,t=9.33,P〈0.01)。两组患者均应用多巴胺(DA)或去甲肾上腺素(NE),无反应组应用DA或NE的剂量均明显高于有反应组[DA(μg·kg^-1·min^-1):14.91±3.78比8.64±1.69,t=-5.02,P〈0.01;NE(μg·kg^-1·min^-1):1.03±0.48比0.38±0.12,t=-3.12,P〈0.01]。无反应组有3例联合应用血管活性药物(DA+NE),而有反应组无联合用药者。两组患者年龄、APACHEⅡ评分、血压、血浆白蛋白水平、输注高渗氯化钠溶液前后血钠水平差异均无统计学意义。结论感染性休克后期患者VP对渗透压改变的调节能力受损,分泌功能下降,VP合成障碍。 Objective To investigate the vasopressin (VP) response to increasing osmotic pressure in the late-phase of septic shock patients. Methods Thirty-seven septic shock patients hospitalized in intensive care unit (ICU) of the First Hospital of Hebei Medical University from January 2012 to September 2013 were enrolled. All patients received 3% hypertonic saline solution infusion. Serum concentrations of VP and sodium were measured before and after hypertonic saline solution infusion. Patients with ratio of difference in VP and sodium before and after infusion of 3% hypertonic saline (AVP/ANa) ~〈0.5 pg/mmol were defined as nonresponders, and who 〉0.5 pg/mmol defined as responders. The age, acute physiological and chronic health evaluation II (APACHE II ) score, blood pressure, albumin level, vasoactive drug between the two groups were also analyzed. Results VP level in the nonresponsive group (n=20, 54.05%) was markedly lowered before (ng/L: 10.41±1.70 vs. 18.25 ±5.90, t=5.29, P〈0.01 ) and after (ng/L: 11.36 ± 1.90 vs. 24.33 ± 5.46, t=9.33, P〈0.01 ) 3% hypertonic saline solution infusion, compared with that in the responsive group (n =17, 45.95% ). All patients in the two groups were given dopamine (DA) or norepinephrine (NE) for maintaining blood pressure, and the dose in the nonresponsive group were higher than those in the responsive group IDA (μg·kg^-1·min^-1) : 14.91 ± 3.78 vs. 8.64 ± 1.69, t=-5.02, P〈0.01; NE (μg·kg^-1·min^-1): 1.03 ± 0.48 vs. 0.38 ± 0.12, t=-3.12, P〈0.011. Three patients were given DA plus NE in the nonresponsive group while patients in the responsive group received only single drug therapy. The age, APACHE II score, blood pressure, albumin level, sodium level before and after hypertonic saline solution infusion between the two groups were not statistically different. Conclusion VP secretion to osmotic challenge was impaired and decreased in the late-phase of septic shock, prompting dysfunction in VP synthesis.
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2014年第1期33-35,共3页 Chinese Critical Care Medicine
基金 基金项目:河北省医药科研重点课题计划(20110319)
关键词 血管加压素 感染性休克 渗透压 高渗 Vasopressin Septic shock Osmolarity Hypertonic
  • 相关文献

参考文献26

  • 1Landry DW,Levin HR,Gallant EM. Vasopressin deficiency contributes to the vasodilation of septic shock[J].{H}CIRCULATION,1997,(05):1122-1125. 被引量:1
  • 2Batista MB,Bravin AC,Lopes LM. Pressor response to fluid resuscitation in endotoxic shock:involvement of vasopressin[J].{H}CRITICAL CARE MEDICINE,2009,(11):2968-2972. 被引量:1
  • 3Jochberger S,D(o)rler J,Luckner G. The vasopressin and copeptin response to infection,severe sepsis,and septic shock[J].{H}CRITICAL CARE MEDICINE,2009,(02):476-482. 被引量:1
  • 4Siami S,Bailly-Salin J,Polito A. Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock[J].{H}CRITICAL CARE MEDICINE,2010,(10):1962-1969. 被引量:1
  • 5Treschan TA,Peters J. The vasopressin system:physiology and clinical strategies[J].{H}ANESTHESIOLOGY,2006,(03):599-612. 被引量:1
  • 6Holmes CL,Patel BM,Russell JA. Physiology of vasopressin relevant to management of septic shock[J].{H}CHEST,2001,(03):989-1002. 被引量:1
  • 7Mutlu GM,Factor P. Role of vasopressin in the management of septic shock[J].{H}Intensive Care Medicine,2004,(07):1276-1291. 被引量:1
  • 8韩旭东,黄晓英.血管加压素在血管舒张性休克中的应用[J].上海医药,2012,33(13):4-7. 被引量:5
  • 9SharsharT,Blanchard A,Paillard M. Circulating vasopressin levels in septic shock[J].{H}CRITICAL CARE MEDICINE,2003,(06):1752-1758. 被引量:1
  • 10赵贤元,皋源,杭燕南,周嘉敏,陶中华,王鲁.外科手术后全身性炎性反应综合征和严重脓毒症患者血浆血管加压素浓度及其相关因素分析[J].中国临床医学,2010,17(4):594-597. 被引量:1

二级参考文献148

共引文献392

同被引文献93

  • 1侯立朝,计根林,熊利泽,陈绍洋,陈敏,霍婷婷,胡文能,王雅丽,汪晨,白晓光.多巴胺联合去甲肾上腺素对感染性休克患者肾脏功能的影响[J].中华外科杂志,2006,44(17):1206-1208. 被引量:13
  • 2Landry DW,Levin HR, Gallant EM,et al. Vasopressin deficiency contributes to the vasodilation of septic shock[J]. Circulation, 1997, 95 : 1122-1125. 被引量:1
  • 3Habib S, Boyer TD.Vasopressin V2-receptor antagonists in patients with Criihosis,ascites and hyponatremia.Therap Adv Gastronen- terol,2012,5(3) :189-197. 被引量:1
  • 4O'Brien AJ,Thakur G,Buckley JF,et al. The pore-forming sub- unit of the K (ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro. Br J Pharmacol, 2005,144(3) :367-375. 被引量:1
  • 5Barrett LK,Orie NN,Taylor V,et al. Differential effects of vaso- pressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis [J]. Crit Care Med, 2007,35 ( 10 ) : 2337 - 2343. 被引量:1
  • 6Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med, 2004,30 : 1276-1291. 被引量:1
  • 7Sharshar T, Blanchard A ,Paillard M, et al. Circulating vasopressin levels in septic shock[J]. Crit Care Med,2003,31:1752-1758. 被引量:1
  • 8Jochberger S, Mayr VD, Luckner G ,et al. Serum vasopressin con- centrations in critically ill patients[J]. Crit Care Med,2006,34: 293-299. 被引量:1
  • 9Russell JA,Walley KR,Singer J,et al. Vasopressin versus nore- pinephrine infusion in patients with septic shock. N Engl J Med, 2008,358 (9) : 877-887. 被引量:1
  • 10Gordon AC,Wang N,Walley KR,et al. The cardiopulmonary ef- fects of vasopressin compared with norepinephrine in septic shock. Chest, 2012,142 ( 3 ) : 593 -605. 被引量:1

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部